ID   U2OS-GFP-HK2
AC   CVCL_C0Q8
DR   PRIDE; PXD028992
DR   Wikidata; Q112930498
RX   PubMed=35609998;
CC   Population: Caucasian.
CC   Characteristics: Transfected with a pCMV6-AC-HK2-GFP construct that contains HK2 c-terminally tagged with turbo-GFP.
CC   Sequence variation: Mutation; HGNC; HGNC:9277; PPM1D; Simple; p.Arg458Ter (c.1372C>T); ClinVar=VCV002445214; Zygosity=Heterozygous (from parent cell line).
CC   Genetic integration: Method=Transfection/transduction; Gene=FPbase; A315M; TurboGFP (Note=Green fluorescent protein from P.plumata).
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:4923; HK2.
CC   Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo.
CC   Omics: Proteomics; Quantitative.
CC   Derived from site: In situ; Bone, tibia; UBERON=UBERON_0000979.
DI   NCIt; C9145; Osteosarcoma
DI   ORDO; Orphanet_668; Osteosarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0042 ! U2OS
SX   Female
AG   15Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 8
//
RX   PubMed=35609998; DOI=10.1093/nar/gkac360; PMCID=PMC9178003;
RA   Watzky M., Huard S., Juricek L., Dairou J., Chauvet C., Coumoul X.,
RA   Letessier A., Miotto B.;
RT   "Hexokinase 2 is a transcriptional target and a positive modulator of
RT   AHR signalling.";
RL   Nucleic Acids Res. 50:5545-5564(2022).
//